4.6 Article

Prognostic model for hepatocellular carcinoma based on anoikis-related genes: immune landscape analysis and prediction of drug sensitivity

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma

Zhao Zhang et al.

Summary: This study explores the significance of anoikis-related genes (ANRGs) in osteosarcoma and their impact on the immune landscape. It establishes a prognostic signature based on ANRGs and develops a model for predicting survival probability in osteosarcoma patients. The study also identifies chemotherapeutic agents suitable for different subtypes of osteosarcoma.

INTERNATIONAL IMMUNOPHARMACOLOGY (2023)

Review Immunology

Exosomes: A potential tool for immunotherapy of ovarian cancer

Xiangjin Gong et al.

Summary: Ovarian cancer is a highly malignant tumor with a poor prognosis. Current treatments, such as chemotherapy and radiotherapy, yield unsatisfactory results. Exosomes, a type of extracellular vesicle, have shown potential as effective carriers of immunotherapeutic drugs. They play a dual role in inhibiting and promoting tumor development and contain genes that could serve as biomarkers for ovarian cancer diagnosis and prognosis. However, further research is needed to explore the clinical application of exosome-based immunotherapy in ovarian cancer.

FRONTIERS IN IMMUNOLOGY (2023)

Article Genetics & Heredity

Identification of miRNA-mediated gene regulatory networks in L-methionine exposure counteracts cocaine-conditioned place preference in mice

Yan Wang et al.

Summary: In this study, it was found that L-methionine can reverse the expression of genes and miRNAs affected by cocaine. Furthermore, L-methionine was shown to counteract the effects of cocaine by modulating the calcium channel gene network and pathways associated with drug addiction. These findings provide insights into the underlying mechanisms of L-methionine in response to cocaine abuse.

FRONTIERS IN GENETICS (2023)

Review Gastroenterology & Hepatology

Influence of diabetes mellitus and effectiveness of metformin on hepatocellular carcinoma

Masafumi Ono et al.

Summary: Hepatocellular carcinoma (HCC) is a common cancer, and diabetes mellitus (DM) is a risk factor for its development. Metformin, a drug for DM, has anticancer effects on HCC and improves prognosis after treatment. This review discusses the mechanisms of hyperglycemia and hyperinsulinemia in HCC carcinogenesis, the carcinogenic effects of DM on HCC by etiology, and the anticancer effects of metformin.

HEPATOLOGY RESEARCH (2023)

Article Gastroenterology & Hepatology

Global burden of liver disease: 2023 update

Harshad Devarbhavi et al.

Summary: Liver disease causes two million deaths annually, accounting for 4% of all deaths worldwide, with a higher prevalence among men. The main causes of death are complications of cirrhosis and hepatocellular carcinoma, while acute hepatitis contributes to a smaller proportion. The major factors leading to cirrhosis globally are viral hepatitis, alcohol consumption, and non-alcoholic fatty liver disease. Drug-induced liver injury is also becoming a significant cause of acute hepatitis. This updated version of the global burden of liver disease focuses on new information related to alcohol-associated liver disease, non-alcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma. Moreover, it gives attention to liver disease burden in the often overlooked region of Africa.

JOURNAL OF HEPATOLOGY (2023)

Article Medical Laboratory Technology

Targeting tumor-associated MUC1 overcomes anoikis-resistance in pancreatic cancer

Mukulika Bose et al.

Summary: Pancreatic cancer, particularly pancreatic ductal adenocarcinoma (PDA), is a major cause of cancer-related deaths in the United States. Surgical resection is the best treatment option, but only a small percentage of patients are eligible. Recurrence and metastasis are the main reasons for mortality. A monoclonal antibody named TAB004 has been developed to target tumor-associated MUC1 (tMUC1), which is expressed in over 80% of PDAs. Treatment with TAB004 has shown significant effects in reducing colony-forming potential in PDA cells and inducing cell death. The mechanism involves disruption of cellular integrity, activation of ER stress and anoikis, and inhibition of oncogenic signaling pathways. TAB004 also exhibited promising results in mouse models, indicating its potential as a prophylactic agent to prevent tumor relapse, metastasis, and increase the efficacy of chemotherapy.

TRANSLATIONAL RESEARCH (2023)

Article Biochemistry & Molecular Biology

Technology Targeted pseudouridylation: An approach for suppressing nonsense mutations in disease genes

Hironori Adachi et al.

Summary: This study presents a targeted PTC pseudouridylation method to suppress nonsense mutations. It can inhibit nonsense-mediated mRNA decay and promote PTC readthrough. It can also be used in combination with antibiotic treatment to improve the suppression effect. Transfection of a designer guide RNA gene can also achieve nonsense suppression in disease model cell lines carrying chromosomal PTC.

MOLECULAR CELL (2023)

Review Gastroenterology & Hepatology

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment

Josep M. Llovet et al.

Summary: Nonalcoholic fatty liver disease (NAFLD), including its more severe manifestation, nonalcoholic steatohepatitis (NASH), has a global prevalence of 20-25% and is a major public health problem. NASH-HCC, influenced by factors such as the immune microenvironment, PNPLA3 mutations, and the microbiome, has unique characteristics compared to other types of HCC and affects both men and women equally. The management of NASH-HCC involves surgery, locoregional therapies, and systemic therapies, with the future focus being on improving surveillance, developing targeted combination therapies, and identifying biomarkers for treatment responders.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)

Article Oncology

Cell Competition Shapes Metastatic Latency and Relapse

Kangsan Kim et al.

Summary: Cell competition leads to the displacement of latent metastatic cells from the primary tumor, with disruption of this process resulting in reduced metastatic incidence. Kidney cancer has enriched tumor subclones with latent metastatic traits, which are associated with rapid onset of metastases and reduced disease-free survival. The findings highlight the importance of cell competition in shaping metastatic latency and relapse.

CANCER DISCOVERY (2023)

Review Virology

Genetic Susceptibility to Hepatocellular Carcinoma in Patients with Chronic Hepatitis Virus Infection

Tsai-Hsuan Yang et al.

Summary: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide. Its risk factors include viral infections, alcohol consumption, obesity, metabolic disease, and aflatoxin exposure. Genetic predisposition and shared environment play important roles in the development of HCC.

VIRUSES-BASEL (2023)

Article Immunology

Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity

Hao Chi et al.

Summary: This study aimed to establish reliable markers based on biologic clock genes to assess the immunotherapy response and prognosis in HNSCC patients. Through analysis of 502 HNSCC samples and 44 normal samples, 6 circadian rhythm-related genes (CRRGs) strongly associated with HNSCC prognosis were identified and a predictive model was constructed. Patients can evaluate their prognosis and immunotherapy outcome based on the risk score generated by this model.

FRONTIERS IN IMMUNOLOGY (2023)

Article Immunology

Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson's disease

Songyun Zhao et al.

Summary: By analyzing 2601 neurotrophic factor-related genes, we identified 12 genes potentially involved in the pathogenesis of Parkinson's disease and the prognosis of glioblastoma multiforme. Machine learning techniques validated 4 genes as reliable diagnostic markers for Parkinson's disease, and 7 genes were found to be highly associated with the prognosis and diagnosis of glioblastoma multiforme. A prognostic risk scoring system based on these genes was developed, and low-risk patients showed better overall survival and response to immunotherapy. EN1 and LOXL1 were identified as potential therapeutic targets for personalized immunotherapy for Parkinson's disease and glioblastoma multiforme.

FRONTIERS IN IMMUNOLOGY (2023)

Article Immunology

Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma

Xin Zhang et al.

Summary: This study identified 28 key sphingolipid genes (SPGs) that impact survival and developed a reliable prognostic model for hepatocellular carcinoma (HCC) patients. The model can assist clinicians in choosing personalized treatments. The study also revealed the connection between sphingolipid-related genes and the immune microenvironment, offering a new approach for immunotherapy. By focusing on crucial sphingolipid genes like SMPD2 and CSTA, the efficacy of anti-tumor therapy can be increased in HCC cells.

FRONTIERS IN IMMUNOLOGY (2023)

Article Immunology

T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing

Hao Chi et al.

Summary: A TEX-based signature was developed using single-cell RNA-seq and high-throughput RNA sequencing to evaluate the prognosis and immunotherapeutic response of HCC patients. The study found that TEX genes were closely associated with HCC prognosis, and patients in the low-risk group had a better overall survival rate. This study provides a new method for assessing immune therapy efficacy and has important implications for future precision immuno-oncology studies.

FRONTIERS IN IMMUNOLOGY (2023)

Article Endocrinology & Metabolism

Identification of copper metabolism-related subtypes and establishment of the prognostic model in ovarian cancer

Songyun Zhao et al.

Summary: This study investigated the impact of genes associated with copper metabolism on the prognosis of ovarian cancer patients, identified different copper metabolism clusters, and established a risk model to evaluate patient prognosis, immunological features, and therapy response. The results provide valuable insights for individualized treatment of ovarian cancer.

FRONTIERS IN ENDOCRINOLOGY (2023)

Review Cell Biology

Role of the tumor microenvironment in malignant melanoma organoids during the development and metastasis of tumors

Siyu Zhou et al.

Summary: Malignant melanoma (MM) is a highly metastatic and aggressive form of skin cancer, with a high risk of death. Immune-checkpoint inhibitor therapy and molecular-targeted therapy have shown significant survival benefits for advanced MM patients. However, low response rates and drug resistance hinder further improvements in efficacy, which are closely linked to the tumor microenvironment (TME).

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)

Review Cell Biology

Understanding and targeting anoikis in metastasis for cancer therapies

Farzad Sattari Fard et al.

Summary: The development of effective cancer treatments requires a detailed understanding of cellular mechanisms involved in cancer progression and metastasis. Anoikis, a special type of apoptosis induced by loss of anchorage, is a driving mechanism in cancer metastasis. This review discusses the mechanisms of gaining anoikis/anoikis resistance phenotype in tumor cells and highlights the significance of anoikis in malignancies for cancer diagnosis and therapy development.

CELL BIOLOGY INTERNATIONAL (2023)

Article Gastroenterology & Hepatology

Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: A large, multicenter study

Ke Su et al.

Summary: This multicenter study aimed to develop a nomogram for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) based on important risk factors. The nomogram showed good performance in predicting the 1-year survival rate for HBV-related HCC.

ANNALS OF HEPATOLOGY (2023)

Article Oncology

Targeting LRRC15 Inhibits Metastatic Dissemination of Ovarian Cancer

Upasana Ray et al.

Summary: This study identifies the role of LRRC15 in promoting ovarian cancer metastasis and demonstrates that the LRRC15-targeted antibody-drug conjugate can suppress ovarian cancer metastasis.

CANCER RESEARCH (2022)

Article Biochemistry & Molecular Biology

Pseudouridine synthases modify human pre-mRNA co-transcriptionally and affect pre-mRNA processing

Nicole M. Martinez et al.

Summary: This study investigates the pseudouridylation of mRNAs in their life cycle and reveals its potential regulatory functions. By analyzing chromatin-associated RNA from human cells, pseudouridines were found in nascent pre-mRNA at regions associated with alternative splicing and near splice sites. In vitro splicing assays demonstrate the direct effect of individual endogenous pre-mRNA pseudouridines on splicing efficiency. The study establishes a potential for cotranscriptional pre-mRNA pseudouridylation to regulate human gene expression via alternative pre-mRNA processing.

MOLECULAR CELL (2022)

Article Multidisciplinary Sciences

Pseudouridine synthase 7 is an opportunistic enzyme that binds and modifies substrates with diverse sequences and structures

Meredith K. Purchal et al.

Summary: This study investigates the contributions of substrate structure and protein sequence to the binding and catalysis of pseudouridine synthase 7 (Pus7). The research reveals that Pus7 is distinct from other Pus family members and has a wider range of substrates. The study also identifies an insertion domain in the protein that fine-tunes Pus7 activity. Furthermore, the research shows that Pus7 prefers substrates with a specific consensus sequence and that RNA secondary structure is not a strong requirement for Pus7 binding. These findings suggest that factors beyond inherent enzyme properties largely dictate Pus7 substrate selection.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Biochemistry & Molecular Biology

Human constitutive androstane receptor represses liver cancer development and hepatoma cell proliferation by inhibiting erythropoietin signaling

Zhihu Li et al.

Summary: The study reveals that reduced expression of human CAR is associated with worse prognosis in hepatocellular carcinoma. Overexpression of CAR in human hepatoma cells can significantly suppress cell proliferation and growth, and affects cell growth through multiple mechanisms.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Gastroenterology & Hepatology

Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma

Abdullah Husain et al.

Summary: In hepatocellular carcinoma (HCC), the Ephrin-A3/EphA2 axis plays a significant role as a hypoxia-sensitive modulator of HCC cell metabolism and a key contributor to HCC initiation and progression.

JOURNAL OF HEPATOLOGY (2022)

Article Cell Biology

NOL12 as an Oncogenic Biomarker Promotes Hepatocellular Carcinoma Growth and Metastasis

Jianfeng Huang et al.

Summary: NOL12 is overexpressed in HCC and associated with poor prognosis, pathological characteristics, and tumor-infiltrating immune cells. Inhibition of NOL12 expression significantly suppresses proliferation and metastasis of HCC cells. The NOL12-related risk signature has independent prognostic value and correlates with immune checkpoint inhibitor response in HCC patients.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)

Article Biochemistry & Molecular Biology

CryoEM structures of pseudouridine-free ribosome suggest impacts of chemical modifications on ribosome conformations

Yu Zhao et al.

Summary: This study characterized the structures and conformations of modified and pseudouridine-free ribosomes using electron cryomicroscopy. It found that pseudouridine stabilizes key functional motifs by establishing water-mediated close contacts with the phosphate backbone, while the absence of pseudouridine leads to abnormal inter-subunit movements.

STRUCTURE (2022)

Article Cell Biology

GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment

Rindert Missiaen et al.

Summary: Hepatocellular carcinoma (HCC) depends on exogenous arginine due to repression of urea cycle gene expression and unique dependence on cationic amino acid transporter SLC7A1. Arginine deprivation induces an integrated stress response, leading to HCC cell-cycle arrest and quiescence. Inhibiting GCN2 in arginine-deprived HCC cells promotes a senescent phenotype, making these cells vulnerable to senolytic compounds. Combined dietary arginine deprivation, GCN2 inhibition, and senotherapy show potential for HCC treatment.

CELL METABOLISM (2022)

Article Immunology

Ensemble deep learning enhanced with self-attention for predicting immunotherapeutic responses to cancers

Wenyi Jin et al.

Summary: This study proposes a reliable approach to predict individual responses to immunotherapies using ensemble learning and self-attention mechanism. The proposed model, ELISE, demonstrated high accuracy in predicting responses to different immunotherapeutic agents in various cancer types.

FRONTIERS IN IMMUNOLOGY (2022)

Article Genetics & Heredity

Integrative multiomics evaluation reveals the importance of pseudouridine synthases in hepatocellular carcinoma

Zhipeng Jin et al.

Summary: This study identified that PUSs are significantly upregulated in hepatocellular carcinoma (HCC) and 5 of them (DKC1, PUS1, PUS7, PUSL1, and RPUSD3) are independent risk factors for patients' overall survival (OS). Both mRNA and protein expressions of these PUSs have high diagnostic value for HCC. Functional analysis revealed that PUSs are mainly involved in pathways such as genetic information processing, substance metabolism, cell cycle, and immune regulation.

FRONTIERS IN GENETICS (2022)

Editorial Material Cell Biology

Editorial: Cell signaling status alteration in development and disease

Jun Wu et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Immunology

Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC

Hao Chi et al.

Summary: This study established a reliable signature based on genes related to NK cells in HNSCC, providing a new perspective for assessing immunotherapy response and prognosis. The 17-NRGs signature demonstrated excellent predictive performance and offered new perspectives for evaluating pre-immune efficacy, facilitating future precision immuno-oncology research.

FRONTIERS IN IMMUNOLOGY (2022)

Review Immunology

IL-7: A promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines?

Yue Zhao et al.

Summary: Cancer vaccines have shown specificity, effectiveness, and safety as an alternative immunotherapeutic strategy. However, maintaining long-term immune memory, especially T cell memory, after vaccination is still a challenge. IL-7, as an adjuvant, has potential in the development of cancer vaccines.

FRONTIERS IN IMMUNOLOGY (2022)

Article Genetics & Heredity

A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration

Hao Chi et al.

Summary: This study constructed a prognostic model for HNSCC using anoikis-related genes (ANRGs) and found differential immune status and drug sensitivity between high-risk and low-risk groups. In addition, through DCA analysis, the researchers demonstrated the potential clinical benefit of the model in the clinical practice.

FRONTIERS IN GENETICS (2022)

Article Biochemistry & Molecular Biology

TCF7L2 promotes anoikis resistance and metastasis of gastric cancer by transcriptionally activating PLAUR

Tao Zhang et al.

Summary: This study identifies urokinase-type plasminogen activator receptor (PLAUR) and transcription Factor 7 Like 2 (TCF7L2) as important factors promoting gastric cancer (GC) metastasis. TCF7L2 regulates PLAUR expression and is an independent risk factor for poor prognosis in GC patients. Therefore, TCF7L2 and PLAUR may be potential targets for therapeutic strategies against GC metastasis.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)

Article Gastroenterology & Hepatology

PPARγ Coactivator-1α Suppresses Metastasis of Hepatocellular Carcinoma by Inhibiting Warburg Effect by PPARγ-Dependent WNT/β-Catenin/Pyruvate Dehydrogenase Kinase Isozyme 1 Axis

Qiaozhu Zuo et al.

Summary: The study revealed that PGC1 alpha is down-regulated in HCC, and its low expression is associated with poor prognosis, vascular invasion, and larger tumor size. PGC1 alpha inhibits HCC metastasis by regulating the WNT/beta-catenin/PDK1 axis.

HEPATOLOGY (2021)

Article Biochemistry & Molecular Biology

GPI-80 Augments NF-κB Activation in Tumor Cells

Yuji Takeda et al.

Summary: Recent studies have found a relationship between GPI-80/VNN2 and malignant tumors. Although GPI-80 mRNA was detectable in tumor cell lines, the levels of GPI-80 protein were significantly lower than in neutrophils. GPI-80 was found in vesicles in GPI-80-expressing cells, with pantetheinase activity and oxidative state augmented in these cells. These observations suggest that GPI-80 affects various tumor responses related to oxidation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Gastroenterology & Hepatology

ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma

Maria Arechederra et al.

Summary: "The study revealed that ADAMTSL5 is highly methylated in hepatocellular carcinoma, associated with tumor formation and resistance to drugs. Targeting ADAMTSL5 can reduce tumorigenic properties of HCC cells and increase sensitivity to clinically relevant drugs. These findings suggest that ADAMTSL5 may serve as a potential marker and drug target in liver cancer."

JOURNAL OF HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications

Terence Kin-Wah Lee et al.

Summary: Hepatocellular carcinoma (HCC) is an aggressive disease with poor prognosis, powered by a subset of cancer stem cells (CSCs). Research on liver CSCs has revealed their heterogeneity and unique immunobiology, suggesting potential for new research directions and therapies for HCC.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Respiratory System

MicroRNA-4732 is downregulated in non-small cell lung cancer and inhibits tumor cell proliferation, migration, and invasion

Xiaochun Tang et al.

Summary: miR-4732-5p expression is decreased in NSCLC and is associated with patient prognosis, potentially inhibiting proliferation, migration, and invasion of NSCLC cells by modulating TSPAN13.

RESPIRATORY MEDICINE AND RESEARCH (2021)

Article Oncology

Acidic extracellular pH induces autophagy to promote anoikis resistance of hepatocellular carcinoma cells via downregulation of miR-3663-3p

Siying Wang et al.

Summary: The acidic tumor microenvironment (TME) promotes autophagy of HCC cells via the AMPK/mTOR pathway, enhancing anoikis resistance. This process is regulated by miR-3663-3p, providing new insights into HCC progression involving the acidic TME.

JOURNAL OF CANCER (2021)

Article Biochemical Research Methods

QuartataWeb: Integrated Chemical-Protein-Pathway Mapping for Polypharmacology and Chemogenomics

Hongchun Li et al.

BIOINFORMATICS (2020)

Article Cell Biology

The small GTPase Rab32 resides on lysosomes to regulate mTORC1 signaling

Kristina Drizyte-Miller et al.

JOURNAL OF CELL SCIENCE (2020)

Article Medicine, Research & Experimental

Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC)

Peng Li et al.

BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2019)

Article Cell Biology

miR-4732-5p promotes breast cancer progression by targeting TSPAN13

Ya-Wen Wang et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Article Biochemistry & Molecular Biology

hTERT promotes tumor progression by enhancing TSPAN13 expression in osteosarcoma cells

Rishi K. Jaiswal et al.

MOLECULAR CARCINOGENESIS (2018)

Article Multidisciplinary Sciences

Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinoma

Yoshinori Ohno et al.

PLOS ONE (2017)

Review Oncology

EMT, cell plasticity and metastasis

Christine L. Chaffer et al.

CANCER AND METASTASIS REVIEWS (2016)

Article Biochemical Research Methods

Robust enumeration of cell subsets from tissue expression profiles

Aaron M. Newman et al.

NATURE METHODS (2015)

Article Biochemistry & Molecular Biology

limma powers differential expression analyses for RNA-sequencing and microarray studies

Matthew E. Ritchie et al.

NUCLEIC ACIDS RESEARCH (2015)

Article Biochemical Research Methods

GSVA: gene set variation analysis for microarray and RNA-Seq data

Sonja Haenzelmann et al.

BMC BIOINFORMATICS (2013)

Review Oncology

Anoikis: an emerging hallmark in health and diseases

M. L. Taddei et al.

JOURNAL OF PATHOLOGY (2012)

Article Biotechnology & Applied Microbiology

clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

Guangchuang Yu et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)

Article Gastroenterology & Hepatology

Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma

Sarah Beseme Nambotin et al.

JOURNAL OF HEPATOLOGY (2011)

Article Medical Informatics

Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers

Andrew J. Vickers et al.

BMC MEDICAL INFORMATICS AND DECISION MAKING (2008)

Article Biochemistry & Molecular Biology

G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression

NL Collins et al.

MOLECULAR AND CELLULAR BIOLOGY (2005)

Review Oncology

A decade's studies on metastasis of hepatocellular carcinoma

ZY Tang et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)